Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 11-11-2006, 11:21 PM #1
reverett123's Avatar
reverett123 reverett123 is offline
In Remembrance
 
Join Date: Aug 2006
Posts: 3,772
15 yr Member
reverett123 reverett123 is offline
In Remembrance
reverett123's Avatar
 
Join Date: Aug 2006
Posts: 3,772
15 yr Member
Default Don't just sit there, do something!!

Maybe it's time to start that career as a professional stock car driver

1: Brain Res Mol Brain Res. 2005 Mar 24;134(1):170-9.

Environmental enrichment in adulthood eliminates neuronal death in experimental
Parkinsonism.

Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.

Department of Developmental Neurobiology, St. Jude Children's Research Hospital,
Mail Stop 323, 332 North Lauderdale, Memphis, TN 38017, USA.

Idiopathic Parkinson's disease (PD) affects 2% of adults over 50 years of age.
PD patients demonstrate a progressive loss of dopamine neurons in the substantia
nigra pars compacta (SNpc). One model that recapitulates the pathology of PD is
the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Here
we show that exposure to an enriched environment (EE) (a combination of
exercise, social interactions and learning) or exercise alone during adulthood,
totally protects against MPTP-induced Parkinsonism. Furthermore, changes in mRNA
expression would suggest that increases in glia-derived neurotrophic factors,
coupled with a decrease of dopamine-related transporters (e.g. dopamine
transporter, DAT; vesicular monoamine transporter, VMAT2), contribute to the
observed neuroprotection of dopamine neurons in the nigrostriatal system
following MPTP exposure. This non-pharmacological approach presents significant
implications for the prevention and/or treatment of PD.

PMID: 15790541 [PubMed - indexed for MEDLINE]
__________________
Born in 1953, 1st symptoms and misdiagnosed as essential tremor in 1992. Dx with PD in 2000.
Currently (2011) taking 200/50 Sinemet CR 8 times a day + 10/100 Sinemet 3 times a day. Functional 90% of waking day but fragile. Failure at exercise but still trying. Constantly experimenting. Beta blocker and ACE inhibitor at present. Currently (01/2013) taking ldopa/carbadopa 200/50 CR six times a day + 10/100 form 3 times daily. Functional 90% of day. Update 04/2013: L/C 200/50 8x; Beta Blocker; ACE Inhib; Ginger; Turmeric; Creatine; Magnesium; Potassium. Doing well.
reverett123 is offline   Reply With QuoteReply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT -5. The time now is 04:23 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.